February 09, 2016
GenomeWeb published an in-depth article on NEUMANN, about the company's products and plans.
February 02, 2016
BUDAPEST, FEBRUARY 03, 2016 – Molecular assays developer NEUMANN Diagnostics Ltd. today unveiled its CONFIDENCE™ molecular test portfolio setting a new standard in cervical cancer screening.
© 2017 Neumann Diagnostics Ltd.